Section Arrow
Quote
MLTX.NASDAQ
- MoonLake Immunotherapeutics
Quotes are at least 15-min delayed:2026/03/02 12:20 EST
Regular Hours
Last
 17.58
+0.08 (+0.46%)
Day High 
17.76 
Prev. Close
17.5 
1-M High
19.49 
Volume 
350.53K 
Bid
17.56
Ask
17.6
Day Low
17 
Open
17.15 
1-M Low
14.47 
Market Cap 
1.24B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 17.9 
20-SMA 16.69 
50-SMA 15.56 
52-W High 62.75 
52-W Low 5.95 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.33/-2.97
Enterprise Value
1.24B
Balance Sheet
Book Value Per Share
4.08
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
IBRXImmunityBio10.56+0.76+7.76%-- 
OCULOcular Therapeutix10.775+1.83+20.46%-- 
QNCXQuince Therapeutics0.1061-0.014-11.66%-- 
RAPTRAPT Therapeutics Inc57.995+0.015+0.03%-- 
QUREuniQure NV10.17-5.41-34.72%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatologyand rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.